Expression of insulin-like growth factor mitogenic signals in adult soft-tissue sarcomas: significant correlation with malignant potential
- 1 February 2004
- journal article
- research article
- Published by Springer Nature in Virchows Archiv
- Vol. 444 (2) , 142-148
Abstract
The insulin-like growth factor (IGF) signal transduction system involves receptors, ligands and binding proteins (IGFBPs) that have been shown to have mitogenic and distinct anti-apoptotic effects on malignant cell lines of both epithelial and mesenchymal origin. Expression of the IGF signal system might be a mechanism by which human soft-tissue sarcomas (STS) obtain a proliferative advantage over normal adjacent tissues. IGFBP2, one of at least six different binding proteins identified to date, is secreted by most sarcoma cell lines and appears to be involved in cell proliferation and transformation. Circulating levels of this protein are markedly increased in malignancy. We have assessed 46 adult STS specimens of low, intermediate and high pathological grade of malignancy for the immunohistochemical expression of IGFBP2, IGF1, IGF2, IGF1 receptor-α and -β (IGF1Rα/β). The protein expression was measured by quantitative color video image analysis and semi-quantitative evaluation, and the measurements correlated well (Spearman, P P<0.05). Multiple regression analysis for both quantitative and semi-quantitative data confirmed the significance of the relationship and independence of the proteins, except IGF2. We concluded that IGFBP2 and IGF1Rβ are independent predictors of the malignant potential of adult STS.Keywords
This publication has 32 references indexed in Scilit:
- Diagnosis of gastrointestinal stromal tumors: A consensus approachHuman Pathology, 2002
- Adjuvant Chemotherapy for Adult Soft Tissue Sarcomas of the Extremities and Girdles: Results of the Italian Randomized Cooperative TrialJournal of Clinical Oncology, 2001
- Elevated Serum Insulin-Like Growth Factor-Binding Protein 2 (IGFBP-2) and Decreased IGFBP-3 in Epithelial Ovarian Cancer: Correlation with Cancer Antigen 125 and Tumor-Associated Trypsin Inhibitor1The Journal of Clinical Endocrinology & Metabolism, 1997
- Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group.Journal of Clinical Oncology, 1996
- Insulin-like growth factor 1 (IGF-1) receptors, IGF-1, and IGF-2 are expressed in primary human sarcomas.1995
- Metastatic Behavior of the RIF-1 Murine Fibrosarcoma: Inhibited by Hypophysectomy and Partially Restored by Growth Hormone ReplacementJNCI: Journal of the National Cancer Institute, 1994
- Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors.1990
- An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I.Proceedings of the National Academy of Sciences, 1987
- Regulation of insulin-like growth factor I gene expression by growth hormone.Proceedings of the National Academy of Sciences, 1986
- Actions of Insulin-Like Growth FactorsAnnual Review of Physiology, 1985